EVENTS:   Best Equity Short Ideas Conference Call 12 - Zach Shannon/Corto Capital Advisors & Craig Huber/Huber Research Partners & Thomas Beevers /Forensic Alpha & Ed Steele/Iron Blue Financials & Bill Campbell/Paragon Intel - 12 Nov 25   Will AI Deflate the World? Macro Lessons from Three Industrial Revolutions and China - Manoj Pradhan/Talking Heads Macro - 13 Nov 25     ROADSHOWS: Forest Products Sector Equity and Commodity Research With Expertise in Distressed Debt - Kevin Mason /ERA Research   •   London   12 - 14 Nov 25       Buyside to Buyside Forum and Expert Calls across TMT, Consumer, Healthcare and Fintech - Andrew Peters /Revelare Partners   •   London   17 - 19 Nov 25       Fundamental US Healthcare Short Ideas - Dr Elliot Favus /Favus Institutional Research   •   London   17 - 19 Nov 25      

Fortnightly Publication Highlighting Latest Insights From IRF Providers

Company Research

Partners Group (PGHN SW) Switzerland

Financials

Forensic Alpha

The level of accrued revenue on the balance sheet stands at a massive CHF 739m - this might not seem like such a big increase from 2021 level of CHF 719m, but consider that performance fees in 2022 were only CHF 269m vs. CHF 1,197m in 2021. It therefore seems odd that the accrued revenue balance increased even while performance fees declined drastically. It is also odd that the "long-term" portion (not expected to convert to cash in the next 12 months) has hardly declined at all. Investors should seek clear explanations from management, especially given the risk around the recognition of performance fees has been picked up as a "Key Audit Matter" in the Auditor's report.

Edition: 157

- 31 March, 2023